Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$60.95

-0.46 (-0.75%)

, SMMT

Summit Therapeutics

$8.65

-0.414 (-4.57%)

11:43
10/04/16
10/04
11:43
10/04/16
11:43

Piper Jaffray ups Sarepta target to $68 on Summit deal

Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.

SRPT

Sarepta

$60.95

-0.46 (-0.75%)

SMMT

Summit Therapeutics

$8.65

-0.414 (-4.57%)

  • 04

    Oct

  • 06

    Nov

SRPT Sarepta
$60.95

-0.46 (-0.75%)

09/21/16
LEER
09/21/16
NO CHANGE
LEER
Market Perform
Previous PTAB ruling remains overhang on Sarepta eteplirsen, says Leerink
Leerink analyst Joseph Schwartz notes that Sarepta (SRPT) has announced favorable Patent Trial and Appeal Board of the U.S. Patent and Trademark Office decisions in favor of its exon 51 and 53 composition of matter patent interference cases against BioMarin (BMRN). However, he points out that these rulings are subject to appeal and a previous ruling from the U.S. Patent Trial and Appeal Board, or PTAB, in favor of BioMarin's method of use patent remains an overhang on the commercialization of Sarepta's eteplirsen. The analyst reiterates a Market Perform rating on Sarepta's shares.
09/23/16
PIPR
09/23/16
NO CHANGE
Target $64
PIPR
Overweight
Sarepta stock issuance strengthens balance sheet, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says Sarepta Therapeutics has a strengthened balance sheet after issuing 5.02M shares at a price of $59.75. Further, for its Exondys51 approval, Sarepta gained a Rare Priority Review Voucher that could be sold to further pad the company's cash position, Tenthoff tells investors in an intraday research note. He reiterates an Overweight rating on the shares with a $64 price target. The stock is down 5% to $57.74 in late afternoon trading.
09/28/16
09/28/16
NO CHANGE

Experts 'fairly upbeat' on Sarepta drug, says RBC Capital
After speaking with three neurologists who treat DMD, RBC Capital analyst Simos Simeonidis says that the doctors were "fairly bullish" on Sarepta's DMD treatment, EXONDYS 51. The doctors expect to use the drug "in essentially all eligible patients," according to the analyst. Simeonidis raised the price target on Sarepta to $108 from $83 and keeps an Outperform rating on the stock.
09/28/16
JMPS
09/28/16
NO CHANGE
JMPS
Street underestimating price of Sarepta drug, says JMP Securities
JMP Securities analyst Liisa Bayko expects the price of Sarepta's Exondys 51 drug will be above the company's projected annual net price of $300,000. She thinks that the price will come in "closer to $538,000 per year on a gross basis, $457,000 net of discounts and compliance." The analyst raised her price target on the shares to $90 from $60 and keeps an Outperform rating on the stock.
SMMT Summit Therapeutics
$8.65

-0.414 (-4.57%)

02/01/16
ADAM
02/01/16
INITIATION
Target $14
ADAM
Buy
Summit Therapeutics initiated with a Buy at Canaccord
Target $14.
02/01/16
02/01/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acadia (ACHC) initiated with an Overweight at KeyBanc... Altisource Residential (RESI) initiated with a Neutral at Nomura... Colony Starwood Homes (SFR) initiated with a Buy at Nomura... EyeGate (EYEG) initiated with a Buy at Rodman & Renshaw... Fortinet (FTNT) initiated with an Outperform at Northland... Halozyme (HALO) initiated with a Buy at Canaccord... Lendingtree (TREE) initiated with an Outperform at Northland... Lindblad Expeditions (LIND) initiated with an Outperform at Credit Suisse... Summit Therapeutics (SMMT) initiated with a Buy at Canaccord... VolitionRx (VNRX) initiated with a Buy at Rodman & Renshaw.
06/21/16
JANY
06/21/16
INITIATION
Target $15
JANY
Buy
Summit Therapeutics initiated with a Buy at Janney Capital
Janney Capital analyst Debjit Chattopadhyay started coverage of Summit Therapeutics with a Buy rating and $15 fair value estimate as he believes the company's pre-clinical data has been compelling and that two upcoming data reads should clarify its outlook and provide a catalyst for the stock.
09/16/16
HCWC
09/16/16
INITIATION
Target $26
HCWC
Buy
Summit Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther initiated Summit Therapeutics with a Buy and a $26 price target saying Ezutromid in DMD can potentially generate $1.2B in global sales in FY26.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$51.11

0.16 (0.31%)

, BAC

Bank of America

$22.79

-0.035 (-0.15%)

11:32
06/26/17
06/26
11:32
06/26/17
11:32
Hot Stocks
Oracle confirms Bank of America as ERP customer »

Oracle (ORCL) announced…

ORCL

Oracle

$51.11

0.16 (0.31%)

BAC

Bank of America

$22.79

-0.035 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

FINL

Finish Line

$13.65

0.92 (7.23%)

11:30
06/26/17
06/26
11:30
06/26/17
11:30
Options
Vote of confidence in Finish Line »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.11

0.156 (0.31%)

11:28
06/26/17
06/26
11:28
06/26/17
11:28
Conference/Events
Oracle management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

OXY

Occidental Petroleum

$59.84

-0.28 (-0.47%)

11:25
06/26/17
06/26
11:25
06/26/17
11:25
Conference/Events
Occidental Petroleum management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HTZ

Hertz

$10.34

0.8046 (8.43%)

11:25
06/26/17
06/26
11:25
06/26/17
11:25
Options
Hertz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$141.72

-1.31 (-0.92%)

11:24
06/26/17
06/26
11:24
06/26/17
11:24
Periodicals
Alibaba-backed Best Inc aiming to raise up to $750M in IPO, WWD reports »

Best Inc., a logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

NFG

National Fuel

$56.53

0.16 (0.28%)

11:22
06/26/17
06/26
11:22
06/26/17
11:22
Conference/Events
National Fuel management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

NFG

National Fuel

$56.53

0.16 (0.28%)

11:22
06/26/17
06/26
11:22
06/26/17
11:22
Conference/Events
National Fuel management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

FN

Fabrinet

$42.84

2.82 (7.05%)

, AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

11:18
06/26/17
06/26
11:18
06/26/17
11:18
Hot Stocks
Fabrinet rises, Applied Optoelectronics sinks after Needham uncovers AWS deal »

Fabrinet (FN) has won a…

FN

Fabrinet

$42.84

2.82 (7.05%)

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

MTSI

MACOM

$58.26

1.76 (3.12%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

ADNT

Adient

$64.75

0.62 (0.97%)

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Conference/Events
Adient to hold a meeting »

EVP & CFO Stafeil,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

ORCL

Oracle

$51.32

0.37 (0.73%)

, BAC

Bank of America

$22.83

0.0134 (0.06%)

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Periodicals
Oracle signs BofA as customer for ERP, financial planning software, CNBC says »

Oracle (ORCL) signed Bank…

ORCL

Oracle

$51.32

0.37 (0.73%)

BAC

Bank of America

$22.83

0.0134 (0.06%)

SAP

SAP

$107.12

-0.36 (-0.33%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

$NSD

NASDAQ Market Internals

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/26/17
06/26
11:16
06/26/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Treasury announced a $40 4-week bill sale for Tuesday »

Treasury announced a $40…

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

ARNC

Arconic

$23.86

-1.68 (-6.58%)

11:12
06/26/17
06/26
11:12
06/26/17
11:12
Periodicals
Arconic discontinuing global Reynobond PE sales for high-rise uses »

CNBC tweets that Arconic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$23.99

-1.55 (-6.07%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Periodicals
Breaking Periodicals news story on Arconic »

Arconic to limit sales of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$3.11

-0.005 (-0.16%)

, WBA

Walgreens Boots Alliance

$76.34

-0.03 (-0.04%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Hot Stocks
Rite Aid jumps after CTFN publishes report »

Shares of Rite Aid (RAD)…

RAD

Rite Aid

$3.11

-0.005 (-0.16%)

WBA

Walgreens Boots Alliance

$76.34

-0.03 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CAR

Avis Budget

$24.24

1.23 (5.35%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Options
Higher volume in Avis fueled by talk about a deal with Google (GOOG) »

Higher volume in Avis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PODD

Insulet

$49.38

0.58 (1.19%)

11:05
06/26/17
06/26
11:05
06/26/17
11:05
Conference/Events
Insulet participates in a conference call with Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$202.32

0.09 (0.04%)

, RYAAY

Ryanair

$109.06

-0.22 (-0.20%)

11:04
06/26/17
06/26
11:04
06/26/17
11:04
Hot Stocks
Boeing reports 153 new orders since last update »

Boeing (BA) on its…

BA

Boeing

$202.32

0.09 (0.04%)

RYAAY

Ryanair

$109.06

-0.22 (-0.20%)

UAL

United Continental

$77.13

0.34 (0.44%)

AER

AerCap

$45.81

0.17 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 07

    Jul

  • 26

    Jul

GRUB

GrubHub

$44.55

-3.1462 (-6.60%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

11:04
06/26/17
06/26
11:04
06/26/17
11:04
Hot Stocks
Battleground: Analysts mull if Amazon more likely to beat, or buy, GrubHub »

In the wake of…

GRUB

GrubHub

$44.55

-3.1462 (-6.60%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

WFM

Whole Foods

$42.95

-0.255 (-0.59%)

YELP

Yelp

$30.29

-0.59 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

V

Visa

$95.43

-0.15 (-0.16%)

11:00
06/26/17
06/26
11:00
06/26/17
11:00
Options
1x2 call spread in Visa tied to delta hedge »

1x2 call spread in Visa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

11:00
06/26/17
06/26
11:00
06/26/17
11:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.